3 Real Estate Stocks Pushing The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 8 points (0.0%) at 16,964 as of Wednesday, July 2, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,180 issues advancing vs. 1,847 declining with 143 unchanged.

The Real Estate industry currently sits down 0.1% versus the S&P 500, which is unchanged. Top gainers within the industry include E-House China Holdings ( EJ), up 6.5%, Weyerhaeuser ( WY), up 1.3%, Nationstar Mortgage Holdings ( NSM), up 0.9%, Icahn ( IEP), up 0.7% and Ocwen Financial ( OCN), up 0.7%. On the negative front, top decliners within the industry include St Joe ( JOE), down 6.9%, Dupont Fabros Technology ( DFT), down 3.8%, Omega Healthcare Investors ( OHI), down 1.9%, Annaly Capital Management ( NLY), down 1.4% and Health Care REIT ( HCN), down 1.3%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Kimco Realty ( KIM) is one of the companies pushing the Real Estate industry higher today. As of noon trading, Kimco Realty is up $0.16 (0.7%) to $23.12 on average volume. Thus far, 1.2 million shares of Kimco Realty exchanged hands as compared to its average daily volume of 2.5 million shares. The stock has ranged in price between $22.87-$23.17 after having opened the day at $23.05 as compared to the previous trading day's close of $22.96.

Kimco Realty Corporation is an independent real estate investment trust. The firm invests in the real estate markets across North America. It is primarily engaged in acquisitions, development, and management of neighborhood and community shopping centers. Kimco Realty has a market cap of $9.4 billion and is part of the financial sector. Shares are up 16.2% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts who rate Kimco Realty a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Kimco Realty as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, increase in net income, reasonable valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Kimco Realty Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Northstar Realty Finance ( NRF) is up $0.12 (0.7%) to $16.92 on heavy volume. Thus far, 4.6 million shares of Northstar Realty Finance exchanged hands as compared to its average daily volume of 4.2 million shares. The stock has ranged in price between $16.75-$17.02 after having opened the day at $16.83 as compared to the previous trading day's close of $16.80.

NorthStar Realty Finance Corp., a real estate investment trust (REIT), operates as a commercial real estate (CRE) investment and asset management company in the United States. Northstar Realty Finance has a market cap of $5.8 billion and is part of the financial sector. Shares are down 37.5% year-to-date as of the close of trading on Tuesday. Currently there are 5 analysts who rate Northstar Realty Finance a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Northstar Realty Finance as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we find that net income has been generally deteriorating over time. Get the full Northstar Realty Finance Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Zillow ( Z) is up $1.16 (0.8%) to $141.86 on light volume. Thus far, 719,800 shares of Zillow exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $140.31-$145.00 after having opened the day at $141.33 as compared to the previous trading day's close of $140.69.

Zillow, Inc. operates real estate and home-related information marketplaces on mobile and the Web in the United States. The company owns and operates Zillow.com. Zillow has a market cap of $4.8 billion and is part of the financial sector. Shares are up 72.1% year-to-date as of the close of trading on Tuesday. Currently there are 3 analysts who rate Zillow a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Zillow as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share. Get the full Zillow Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the real estate industry could consider iShares Dow Jones US Real Estate ( IYR) while those bearish on the real estate industry could consider ProShares Short Real Estate Fund ( REK).

null

More from Markets

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug